MDRX · As filed with the SEC
Veradigm cash flow statement, by quarter
The statement as Veradigm presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q4 2024 3 months ended Dec 31, 2024 | Q4 2022 3 months ended Dec 31, 2022 | Q3 2022† 3 months ended Sep 30, 2022 | Q2 2022† 3 months ended Jun 30, 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Cash flows from financing activities: | ||||
| Credit facility payments | — | — | 0† | (175,000,000)† |
| Cash, cash equivalents and restricted cash, beginning of period | 447,900,000 | 501,904,000 | 521,471,000 | 152,605,000 |
| Cash, cash equivalents and restricted cash, end of period | 294,253,000 | 447,900,000 | 501,904,000 | 521,471,000 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.